Why Partner with Delonix?
Partner with Delonix, a pioneering force in synthetic biology, where innovation meets impact in bacterial vaccine development. Our world-leading pathogen editing capabilities have enabled us to build a robust pipeline of next-generation bacterial vaccines.
We offer partners access to our cutting-edge technology platforms via flexible partnership models including product out-licensing, co-development or contracted services opportunities. Join us in accelerating the development of next-generation vaccines to address critical global health challenges.
One-stop pathogen genome editing
End-to-end bacterial vaccine development
Rapid development track records
01Product Out-licensing
Leveraging Delonix's multiple proprietary vaccine development platforms, we have
successfully incubated a range of first-in-class and best-in-class bacterial vaccine candidates at various stages of development. We aim to maximize the value of our pipeline by granting
full or region-specific licenses to reliable partners.
02Co-Discovery / Co-Development
Delonix seeks to combine its early discovery and pathogen genome editing capabilities, including multiple proprietary technology platforms, with potential industry partners'
resources and expertise to co-discover and co-develop innovative bacterial vaccines.
03Research Collaborations / Contracted Services
Partner with us to accelerate your vaccine development journey. Delonix also offers
comprehensive research collaboration and contract services leverage cutting-edge
proprietary platforms and deep expertise in vaccine development. From initial design through vaccine process and evaluation, our experienced team delivers end-to-end
solutions tailored to your needs.